TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Tarpoon Bioscience AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
852
|
1,295
|
1,347 |
| Financial expenses |
0
|
0
|
130 |
| Earnings before taxes |
520
|
237
|
150 |
| EBITDA |
489
|
226
|
281 |
| Total assets |
3,342
|
2,980
|
2,904 |
| Current assets |
1,135
|
918
|
899 |
| Current liabilities |
97
|
225
|
191 |
| Equity capital |
3,076
|
2,619
|
2,567 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.0%
|
87.9%
|
88.4% |
| Turnover per employee |
852
|
1,295
|
1,347 |
| Profit as a percentage of turnover |
61.0%
|
18.3%
|
11.1% |
| Return on assets (ROA) |
15.6%
|
8.0%
|
9.6% |
| Current ratio |
1170.1%
|
408.0%
|
470.7% |
| Return on equity (ROE) |
16.9%
|
9.0%
|
5.8% |
| Change turnover |
-535
|
-11
|
30 |
| Change turnover % |
-39%
|
-1%
|
2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.